What is the best approach to assess and treat xerostomia (dry oral mucosa) in a patient on chronic dialysis?

Management of Xerostomia in Dialysis Patients

Xerostomia in dialysis patients requires a systematic approach focused on meticulous oral hygiene, adequate hydration within fluid restrictions, elimination of xerostomizing medications when possible, and use of mechanical salivary stimulants, as pharmacological treatments have shown limited effectiveness in this population.

Understanding the Problem

Xerostomia is a frequent and debilitating symptom in hemodialysis patients, affecting approximately 56% of this population 1. The condition results from multiple factors including reduced salivary flow secondary to salivary gland parenchymal fibrosis and atrophy, fluid intake restrictions to maintain correct fluid volume balance, xerostomizing medications, advanced age, and mouth breathing 2, 3. Dialysis patients demonstrate higher concentrations of urea, creatinine, sodium, potassium, chloride, and phosphorus in saliva compared to healthy individuals, with elevated salivary pH and buffering capacity 2.

Assessment Protocol

Clinical Evaluation

• Inspect the oral mucosa daily for lesions, mucosal injury, gingival inflammation, and signs of candidiasis, which occur more frequently in dialysis patients with xerostomia 2
• Assess fluid restriction status and current interdialytic weight gain patterns, as thirst correlates positively with interdialytic weight gain 1
• Review all medications systematically for anticholinergic properties, particularly benzodiazepines (which increase xerostomia risk 5.96-fold), antihypertensives, and other xerostomizing agents 4, 1
• Evaluate for hypertension, which increases xerostomia risk 5.24-fold in dialysis patients 1
• Measure salivary flow if resources permit: unstimulated whole saliva <0.1 mL/min or stimulated whole saliva <0.7 mL/min indicates hyposalivation 5

Core Management Strategy

Daily Oral Hygiene Protocol

Implement a rigorous oral hygiene routine as the foundation of xerostomia management to prevent secondary complications including candidiasis, dental caries, periodontal disease, and mucosal lesions 2:

• Brush teeth twice daily (after meals and at bedtime) using a soft toothbrush with the Bass or modified Bass method 2
• Replace toothbrush monthly to maintain optimal softness and reduce bleeding risk 2, 6
• Use mild fluoride-containing, non-foaming toothpaste to minimize irritation while providing caries protection 2, 6
• Rinse with alcohol-free mouthwash at least four times daily (upon awakening and after each brushing) for approximately 1 minute with 15 mL, then spit out 2
• Wait 30 minutes after rinsing before eating or drinking 2
• Store toothbrush with bristles facing upward after thorough rinsing with water 2, 6

Hydration and Lubrication

• Drink ample fluids within prescribed fluid restrictions to keep the mouth moist, balancing xerostomia relief against interdialytic weight gain 2
• Lubricate lips with sterile petroleum jelly, lip balm, or lip cream, but avoid chronic petroleum jelly use as it promotes mucosal cell dehydration and increases secondary infection risk 2

Denture Management

• Remove dentures before performing oral care and brush them with toothpaste, rinsing thoroughly with water 2
• Defer wearing dental prostheses as much as possible until oral tissues heal if mucosal injury is present 2
• Soak dentures for 10 minutes in antimicrobial solution (e.g., 0.2% chlorhexidine) before insertion if hospitalized 2

Therapeutic Interventions

Mechanical Salivary Stimulation

Use mechanical stimulation as first-line therapy for patients with residual salivary gland function, as this approach is more beneficial than salivary substitutes 4:

• Sugar-free chewing gum to stimulate salivary flow 5
• Mouthwash as part of the oral hygiene routine 7
• Acupressure or transcutaneous electrical stimulation may provide modest benefit, though long-term effectiveness requires further investigation 7

Pharmacological Options (Limited Efficacy)

Pharmacological treatments have shown limited or short-term effectiveness in dialysis patients 3, 7:

• Cevimeline (30 mg three times daily) is FDA-approved for Sjögren's syndrome and acts as a cholinergic agonist binding to muscarinic receptors to increase exocrine gland secretion, with 76% of patients reporting global improvement in dry mouth symptoms 8
• Pilocarpine has been attempted but shows limited effectiveness in dialysis patients 3
• ACE inhibitors alone or combined with angiotensin-receptor blockers have proven ineffective or only effective short-term 3
• Saliva substitutes are generally ineffective or provide only temporary relief 3, 7

Medication Review and Adjustment

Collaborate with the nephrologist to review and potentially adjust xerostomizing medications, particularly benzodiazepines and anticholinergic agents, as medication alteration plays an important role in xerostomia management 4, 1.

Prevention of Complications

Avoid Irritants and Trauma

• Eliminate smoking and alcohol consumption completely 2
• Avoid irritating foods including tomatoes, citrus fruits, hot drinks, and spicy, hot, raw, or crusty foods 2
• Have the dental team eliminate sources of mechanical trauma such as ill-fitting prostheses and fractured teeth 2

Monitor for Secondary Infections

Dialysis patients with xerostomia have increased risk of candidiasis and other oral infections due to altered immune function and reduced salivary antimicrobial properties 2. Watch for white patches, erythematous areas, or angular cheilitis requiring antifungal treatment.

Dental Caries Prevention

Implement aggressive caries prevention given the increased risk from reduced salivary flow and altered salivary composition 2, 5:

• Topical fluoride interventions as recommended by the dental team 5
• Regular dental visits for professional monitoring and early intervention 2

Special Considerations for Dialysis Timing

Schedule dental procedures and intensive oral care on non-dialysis days or the day after hemodialysis to minimize bleeding risk from anticoagulants (heparin with 1-2 hour half-life; low-molecular-weight heparin with ~4 hour half-life) used during dialysis 2.

Quality of Life Impact

Xerostomia significantly impairs quality of life in dialysis patients, causing difficulties with chewing, swallowing, tasting, and speaking, while increasing interdialytic weight gain from compensatory fluid intake 3, 7, 1. The mean Oral Health Impact Profile (OHIP-14) score in dialysis patients with xerostomia is 24.38±11.98, reflecting substantial functional and psychosocial impact 1.

Common Pitfalls to Avoid

• Do not start interdental cleaning (floss, toothpicks, brushes) during active mucosal injury if the patient was not previously using these regularly, as this can break the epithelial barrier and cause gingival bleeding 2, 6
• Avoid alcohol-containing mouthwashes as alcohol exacerbates oral discomfort and dries inflamed tissues 6
• Do not rely solely on pharmacological treatments as they have proven largely ineffective in dialysis patients; focus on comprehensive oral hygiene and mechanical stimulation 3, 7
• Avoid chronic petroleum jelly use on lips despite its lubricating properties, as it promotes mucosal dehydration and increases infection risk 2